Literature DB >> 21255981

Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis.

Sayaka Hayashida1, Hiroshi Uchi, Yoichi Moroi, Masutaka Furue.   

Abstract

BACKGROUND: Clinical significance of circulating CD4(+) T cell subsets, including T-helper (Th)1, Th2, Th17 and regulatory T (Treg) cells, in patients with atopic dermatitis (AD) remains unclear. No previous studies have simultaneously evaluated the four T cell subset profiles in AD.
OBJECTIVE: The aim of the present study was to explore whether the percentage of these four subsets of CD4(+) T cells correlate to the severity parameters of AD patients.
METHODS: Intracellular expression of interferon (IFN)-γ, interleukin (IL)-4, IL-17 and forkhead box P3 (Foxp3) in CD4(+) T cells was evaluated in peripheral blood mononuclear cells from normal controls and patient with AD as well as with chronic eczema using a flow cytometer. Serum CCL17 levels were measured as an objective severity parameter of AD together with percentage of eosinophils and serum IgE levels.
RESULTS: In AD patients, the number of Th1 (IFN-γ(+)) and Th17 (IL-17(+)) subsets was significantly decreased, but that of Th2 (IL-4(+)) and Treg (Foxp3(+)) subsets was similar to that of normal controls. The T cell subset profiles of patients with chronic eczema were not different with those of normal controls. The frequency of Th17cells, particularly that of the IFN-γ(nega)IL-17(+) subset, showed a significant negative correlation with CCL17, IgE and eosinophil levels in AD patients. This was, however, not the case in Th1, Th2 and Treg cells.
CONCLUSION: Decreased circulating Th17 cells might contribute to activity of AD.
Copyright © 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21255981     DOI: 10.1016/j.jdermsci.2010.10.013

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  18 in total

1.  Relationship Between Serum Interleukin-17F Level and Severity of Atopic Dermatitis in Children.

Authors:  Young A Park; Yoon Hee Kim; In Suk Sol; Seo Hee Yoon; Jung Yeon Hong; Mi Na Kim; Kyung Eun Lee; Kyung Won Kim; Kyu-Earn Kim; Myung Hyun Sohn
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-06-01       Impact factor: 1.349

2.  FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions.

Authors:  Joabe S Pereira; Bárbara V Monteiro; Cassiano F Nonaka; Éricka J Silveira; Márcia C Miguel
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

Review 3.  Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Authors:  Sheila Krishna; Lloyd S Miller
Journal:  Semin Immunopathol       Date:  2011-11-06       Impact factor: 9.623

4.  Severe refractory atopic dermatitis in an adolescent patient successfully treated with ustekinumab.

Authors:  Anna Agusti-Mejias; Francesc Messeguer; Ramón García; Isabel Febrer
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

Review 5.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

6.  Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages.

Authors:  Amy T Hsu; Tanya J Lupancu; Ming-Chin Lee; Andrew J Fleetwood; Andrew D Cook; John A Hamilton; Adrian Achuthan
Journal:  J Biol Chem       Date:  2018-06-05       Impact factor: 5.157

7.  Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production.

Authors:  Monika Majewska-Szczepanik; Philip W Askenase; Francis M Lobo; Katarzyna Marcińska; Li Wen; Marian Szczepanik
Journal:  J Allergy Clin Immunol       Date:  2016-01-22       Impact factor: 10.793

Review 8.  Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.

Authors:  Elena Campione; Caterina Lanna; Laura Diluvio; Maria Vittoria Cannizzaro; Sandro Grelli; Marco Galluzzo; Marina Talamonti; Margherita Annicchiarico-Petruzzelli; Mara Mancini; Gerry Melino; Eleonora Candi; Gianfranco Schiavone; Ying Wang; Yufang Shi; Luca Bianchi
Journal:  Cell Cycle       Date:  2020-01-05       Impact factor: 4.534

9.  The emerging role of interleukin-21 in allergic diseases (Review).

Authors:  Fang Gong; Qiang Su; Yu Hong Pan; Xuan Huang; Wei Hong Shen
Journal:  Biomed Rep       Date:  2013-09-12

Review 10.  Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics.

Authors:  Yasaman Mansouri; Emma Guttman-Yassky
Journal:  J Clin Med       Date:  2015-04-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.